Funded Tech Companies
Crossbow Therapeutics
Operating out of Cambridge, Crossbow Therapeutics has funding from Eli Lilly and Company, Pfizer Venture Investments and Mirae Asset Venture Investment.
Company Overview
Company Name
Crossbow Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1030 Massachusetts Ave. 210
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Company Background Information
Overview
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company's T-Bolt� therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow's efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/11/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Briggs Morrison
Chief Scientific Officer
Dmitri Wiederschain
Co-Founder
Geraldine Paulus
Company Investors
- Eli Lilly and Company
- Pfizer Venture Investments
- Mirae Asset Venture Investment
- BVF Partners
- Polaris Partners
- MPM Capital
- Mirae Asset Capital
Browse more funded tech companies:
Crossbow Technology | CrossBridge Bio
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs